• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1900025 RO7198574 HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB Injection Biological Products Import Drug Application 2019-03-11 F.Hoffmann-La Roche Ltd F Hoffmann-La Roche Ltd(Switzerland) In Review 2019-03-08 view
JXSL2200024 RO7198574 HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB Injection Biological Products(2.2) Import Drug Application 2022-03-07 view
JXSL2300039 RO7198574 HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB Injection Biological Products(2.2) Import Drug Application 2023-02-22 view
JXSB2000038 RO7198574 HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB Injection Biological Products Supplementary Application 2020-11-26 F.Hoffmann-La Roche Ltd F Hoffmann-La Roche Ltd(Switzerland) In Review 2020-11-25 view
JXSL2300038 RO7198574 HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB Injection Biological Products(2.2) Import Drug Application 2023-02-22 view
JXSB2000039 RO7198574 HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB Injection Biological Products Supplementary Application 2020-11-26 F.Hoffmann-La Roche Ltd F Hoffmann-La Roche Ltd(Switzerland) In Review 2020-11-25 view
JXSL1900024 RO7198574 HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB Injection Biological Products Import Drug Application 2019-03-11 F.Hoffmann-La Roche Ltd F Hoffmann-La Roche Ltd(Switzerland) In Review 2019-03-08 view
JXSL2200023 RO7198574 HYALURONIDASE;PERTUZUMAB;TRASTUZUMAB Injection Biological Products(2.2) Import Drug Application 2022-03-07 view